Table 3 Pathological aspects, staging and treatment of patients with penile cancer.
From: Profile of patients with penile cancer in the region with the highest worldwide incidence
% (N) | |
|---|---|
Tumor size [mean (variation)] | 4.50 cm (0.7–10 cm) |
Tumor topography | |
Glans | 47 (52/112) |
Glans and foreskin | 25 (28/112) |
Glans and corpus | 10 (11/112) |
Foreskin | 3 (3/112) |
Foreskin and corpus | 1 (1/112) |
Glans, foreskin and corpus | 14 (16/112) |
Histological subtypes | |
Usual | 40 (44/110) |
Warty | 33 (36/110) |
Basaloid | 5 (5/110) |
Mixed* | 25 (27/110) |
Others** | 5 (6/110) |
Histological grade | |
Grade I | 13 (14/111) |
Grade II | 46 (51/111) |
Grade III | 41 (46/111) |
Primary tumor (T) | |
Tis | 2 (2/111) |
T1(a,b) | 14 (16/111) |
T2 | 29 (32/111) |
T3 | 46 (51/111) |
T4 | 7 (8/111) |
Tx | 2 (2/111) |
Type of surgery | |
Parcial penectomy | 64 (74/116) |
Total penectomy | 26 (30/116) |
Emasculation | 7 (8/116) |
Others (glansectomy, postectomy and excision) | 3 (4/116) |
Lymphadenectomy | |
Unilateral | 20 (17/86) |
Bilateral | 32 (28/86) |
Not performed | 48 (41/86) |
